Sienna Biopharmaceuticals Inc (SNNAQ)
0.00
USD |
OTCM |
May 24, 16:00
Sienna Biopharmaceuticals Total Liabilities (Quarterly): 20.39M for Sept. 30, 2019
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2019 | 20.39M |
| June 30, 2019 | 80.64M |
| March 31, 2019 | 81.77M |
| December 31, 2018 | 80.72M |
| September 30, 2018 | 79.70M |
| June 30, 2018 | 80.19M |
| Date | Value |
|---|---|
| March 31, 2018 | 47.12M |
| December 31, 2017 | 45.65M |
| September 30, 2017 | 53.05M |
| June 30, 2017 | 48.00M |
| March 31, 2017 | 47.90M |
| December 31, 2016 | 40.26M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
20.39M
Minimum
Sep 2019
80.64M
Maximum
Jun 2019
50.52M
Average
50.52M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 0.9087M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 43.49M |
| Shareholders Equity (Quarterly) | 23.10M |